These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12821939)

  • 1. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
    Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
    Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Jun downregulates the alpha 2 (I) collagen target gene indirectly through Sp1/3.
    Chamboredon S; Castellazzi M
    Oncogene; 2005 Apr; 24(15):2547-57. PubMed ID: 15735704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E; Perez S; Castellazzi M
    Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3.
    Gaudreault M; Vigneault F; Leclerc S; Guérin SL
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3490-505. PubMed ID: 17652716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
    Vial E; Castellazzi M
    Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG; Schneider ML; Bister K; Hartl M
    Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
    Zelko IN; Folz RJ
    Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
    Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
    Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
    Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
    J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM; Xie Z; Young MF; Nielsen KL
    J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families.
    Lui WY; Sze KL; Lee WM
    J Cell Physiol; 2006 Apr; 207(1):144-57. PubMed ID: 16250013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential and antagonistic effects of v-Jun and c-Jun.
    Gao M; Morgan I; Vogt PK
    Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
    Hartl M; Reiter F; Bader AG; Castellazzi M; Bister K
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13601-6. PubMed ID: 11698665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells.
    Li T; Chen YH; Liu TJ; Jia J; Hampson S; Shan YX; Kibler D; Wang PH
    Circ Res; 2003 Dec; 93(12):1202-9. PubMed ID: 14593001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.